SF Dental Implants Urges Second Opinions for Better Outcomes
August 25, 2025 — San Francisco Dental Implant Center emphasizes second opinions for dental implants, using advanced tech for better surgical outcomes. Learn how it saves time and money.
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
August 25, 2025 — San Francisco Dental Implant Center emphasizes second opinions for dental implants, using advanced tech for better surgical outcomes. Learn how it saves time and money.
August 23, 2025 — Boone Heart Institute hosts Summit Conference 2025 on preventive cardiology, focusing on atherosclerosis research and innovative treatment strategies for healthcare professionals.
August 22, 2025 — BayCare Health System ranks No. 17 on 2025 PEOPLE Companies That Care list, recognized as top healthcare system nationally for exceptional workplace culture and community care.
August 22, 2025 — Fifty1 Labs partners with ViRx@Stanford to use AI for rapid antiviral drug repurposing, accelerating pandemic response and strengthening global biosecurity against emerging viral threats.
August 22, 2025 — New research reveals doctors may become overly dependent on AI in medical screenings. Study highlights both benefits and risks of artificial intelligence in healthcare diagnostics and patient care.
August 22, 2025 — Groundbreaking therapy using infant mitochondria shows promise in reversing aging effects. Learn about this innovative approach to cellular rejuvenation and its potential impact on age-related diseases.
August 22, 2025 — Calidi Biotherapeutics raises $6.9M in public offering to advance Redtail platform for metastatic cancer treatment. Clinical-stage company developing targeted genetic medicine delivery systems.
August 22, 2025 — ABVC BioPharma receives $100K from ForSeeCon for Vitargus®, a biodegradable eye implant, in a deal worth up to $63.5M, targeting the growing $4B vitreous substitute market.
August 22, 2025 — Ed Hale switches to Republican to challenge Gov. Wes Moore in 2026. Maryland faces record heat deaths, energy poverty, and mental health care delays amid political shifts.
August 22, 2025 — Creative Biolabs integrates CAR-T and TIL therapy platforms for advanced cancer immunotherapy development. One-stop solution for researchers and biotech startups.
August 22, 2025 — Kennedy Krieger Institute ranks among Maryland's best employers on Forbes 2025 list, recognized for exceptional workplace culture and neurological care excellence.
August 21, 2025 — Brightview Senior Living named to 2025 PEOPLE Companies That Care list, ranking No. 77 based on employee surveys and recognition for workplace excellence in senior care.
August 21, 2025 — HeartBeam strengthens cardiac monitoring with new patents for its 3D ECG technology, enabling portable heart health insights and transforming remote cardiac care management.
August 21, 2025 — HAWC opens One Safe Place Houston, a 5.5-acre campus providing comprehensive support for domestic violence and sexual assault survivors with housing and integrated services.
August 21, 2025 — Clene Inc. plans NDA submission for CNM-Au8 in ALS by end of 2025. FDA meetings scheduled, neurofilament data expected Q4. $7.3M cash extends runway to 2026.
August 21, 2025 — Jupiter Neurosciences launches Nugevia with JOTROL technology, delivering 8-10x higher resveratrol bioavailability for brain health and longevity benefits without GI side effects.
August 21, 2025 — MedCognetics and AKARUI deploy AI mammography in rural India, using mobile vans with real-time cancer detection to address radiologist shortages and improve healthcare access.
August 21, 2025 — MIT researchers develop AI method to design nanoparticles for improved RNA vaccine delivery. Breakthrough published in Nature Nanotechnology with implications for medical technology and AI companies.
August 21, 2025 — Columbia University scientists develop bacteria-based Trojan horse system to deliver cancer-killing viruses into tumors while evading immune detection. Breakthrough cancer treatment approach.
August 21, 2025 — ReAlta Life Sciences receives EMA Orphan Drug Designation for RLS-0071 treating Graft-versus-Host Disease. Novel peptide therapy shows promise for steroid-refractory patients.